finafloxacin · Fonseca Biosciences · NDA 206307
Xtoro
Earliest generic entry, as listed
21 Nov 2033
Blocked by patent: US 9504691.
Listed patents · 4 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9504691 | product, use U-1679 | 21 Nov 2033 |
| US 8536167 | use U-1679 | 8 Aug 2031 |
| US 9119859 | use U-1679 | 2 Jul 2030 |
| US 9993483 | product | 2 Jul 2030 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 206307 · 001 · RLD | suspension/drops, otic | 0.3% | 21 Nov 2033 |